Lifeist Wellness Inc. (“Lifeist” or the “Company”)
(TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a
health-tech company that leverages advancements in science and
technology to build breakthrough ventures that transform human
wellness, is pleased to announce that Andrea Judge, the CEO of its
U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra")
sat down with six-time MLB All-Star, three-time Silver Slugger, and
Olympic medal winner José Bautista at his gym, Diesel Optimization
in Tampa, for his first professional interview about his
collaboration with Mikra on
FOCUS and his approach
to entrepreneurship, wellness and life. Mikra’s new product
combines a precision blend of citicoline, tyrosine and pure lion's
mane mushroom to deliver improved memory, total concentration and
faster cognition without any caffeine or stimulants.
FOCUS is anticipated to launch in September.
“It was such a pleasure to sit down and
interview José in person,” said Andrea Judge, CEO of Mikra. “His
contributions to the scientific development and marketing plan for
FOCUS have been absolutely essential, we could not
have made this product without him. As we now prepare to launch,
the time felt right to pause for a moment and reflect on José’s
approach to business, to wellness and to life. The cameras were
rolling for this stimulating conversation, and we look forward to
sharing the interview with everyone soon.”
FOCUS combines the clinically
studied neuroprotective and cognition-enhancing effects of pure
citicoline with the performance-preserving and enhancing effects of
tyrosine and pure lion’s mane mushroom. A systematic review of the
medical use of citicoline published in the Swiss journal Nutrients
found:
“...In research based on animals and humans, it
was proved that citicoline is beneficial in the regeneration of
neurons, can increase levels of neurotransmitters, and has a
positive impact on cognitive functions.”1
A Mt. Sinai Hospital clinical abstract on the medical use of
tyrosine reported:
“...Researchers believe that, under stress, the
body isn't able to make enough tyrosine from phenylalanine. Some
animal and human studies suggest that tyrosine supplements may help
improve memory and performance under psychological stress... One
study suggests that taking tyrosine may help you be more alert
after sleep deprivation.”2
Finally, a landmark Japanese randomized control
trial of lion’s mane mushroom demonstrated:
“MMSE [Mini Mental State Examination] alone
showed that oral intake of H. erinaceus significantly improved
cognitive functions and prevented deterioration. We speculate that
various chemical compounds, including hericenones, in the mushroom
have multiple effects to the brain neural networks and improve
cognitive functions.”3
FOCUS features a proprietary
precisely dosed blend of citicoline, tyrosine and pure lion's mane
mushroom as its primary active ingredients. All three have been
extensively studied and convincingly found to support enhanced
focus, improved memory and clearer cognition in published,
peer-reviewed clinical research.
Mikra is pushing biosciences beyond the expected
with the belief that it is possible to add more active, vigorous,
enjoyable, and valuable years to your life through protecting and
maintaining your cellular health.
Lifeist is committed to bringing natural
products backed by real science to market and looks forward to
reaching many more customers in 2024 and beyond.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic
wellness revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: Mikra, a biosciences
and consumer wellness company developing and selling innovative
products for cellular health; and CannMart, which operates a B2B
wholesale distribution business facilitating recreational cannabis
sales to Canadian provincial government control boards including
for CannMart Labs, a BHO extraction facility producing high margin
cannabis 2.0 products.
Information on Lifeist and its businesses can be
accessed through the links below:
www.lifeist.com https://wearemikra.com/
https://cannmart.com
Contact: Meni MorimCEOLifeist
Wellness Inc.Ph: 647-362-0390 Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to the
anticipated delivery of FOCUS to customers at the
end of the third quarter of this year and expectations relating to
Mikra’s future introduction of new products and reaching additional
customers in 2024, are made as of the date of this news release and
are based on assumptions management believed to be reasonable at
the time such statements were made, including without limitation,
expectations that the manufacturing of FOCUS is
successfully completed in a timely manner, the effectiveness and
benefits of FOCUS are as anticipated, its
expectation that the nutraceutical market will develop as currently
anticipated, the nutraceutical market will continue to be a
multi-billion dollar high-margin market, the introduction of new
products and brands will generate additional revenue, expectations
that FOCUS and other new nutraceutical products to
be developed by Mikra will gain market acceptance along with the
expansion of the market for nutraceutical products, as well as
other considerations that are believed to be appropriate in the
circumstances. While we consider these assumptions to be reasonable
based on information currently available to management, there is no
assurance that such expectations will prove to be correct. By its
nature, forward-looking information is subject to inherent risks
and uncertainties that may be general or specific and which give
rise to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct, and that objectives, strategic
goals and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this news release. Such factors
include, without limitation: unforeseen delays in the manufacturing
and/or sale of FOCUS, the inability of the Company
to develop Mikra’s business as anticipated, unanticipated changes
to current regulations that would adversely impact Mikra’s
business, unforeseen developments that would delay Mikra’s ability
to sell newly developed nutraceutical products, the risk that the
expected demand for nutraceutical products in general and those of
Mikra in particular does not develop as anticipated and risks
relating to the Company’s ability to execute its business strategy
and the benefits realizable therefrom. Additional risk factors can
also be found in the Company’s current MD&A filed under the
Company’s SEDAR+ profile at www.sedarplus.ca. Readers are cautioned
not to put undue reliance on forward-looking information. The
Company undertakes no obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise, except as required by
applicable law. Forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/4ae12c20-e959-4163-82ac-5a4dbe1b0406
Source: Lifeist Wellness Inc.
1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601330/2
https://www.mountsinai.org/health-library/supplement/tyrosine3
https://pubmed.ncbi.nlm.nih.gov/31413233/
Lifeist Wellness (TSXV:LFST)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Lifeist Wellness (TSXV:LFST)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024